Grants and Contributions:
Title:
2425-HQ-000003
Agreement Number:
2425-HQ-000003
Agreement Value:
$265,276,781.00
Agreement Date:
Mar 15, 2024 - Mar 31, 2029
Description:
To enhance the health of Canadians and health system sustainability by promoting the cost-effective and optimal use of drugs and other health technologies.
Organization:
Health Canada
Expected Results:
Health care decision-makers access evidence on drugs and medical devices and are equipped with the knowledge, skills and supports to incorporate evidence in decision-making.
Location:
Ottawa, Ontario, CA K1S 5S8
Reference Number:
271-2024-2025-Q4-00111
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
132633868
Recipient Type:
Other
Additional Information:
The total agreement value previously disclosed has been updated to reflect an increase resulting from this amendment, and the agreement end date has been updated to reflect an extension.
Amendment Date
Mar 10, 2025
Recipient's Legal Name:
Canadian Agency for Drugs and Technologies in Health
Program:
Contribution to the Canadian Agency for Drugs and Technologies in Health
Program Purpose:
Canadian Health Systems and Programs
Amendments: